Cardiac Amyloidosis

Cardiac Amyloidosis is a rare but serious condition characterized by the abnormal buildup of amyloid proteins in the heart tissue. These proteins, often originating from misfolded antibodies or other precursor proteins, form insoluble fibrils that deposit in the heart, affecting its structure and function. As these deposits accumulate, the heart's ability to pump blood efficiently is compromised, leading to symptoms such as fatigue, shortness of breath, and swelling in the legs. The condition is challenging to diagnose due to its diverse clinical presentation, and early detection is crucial for effective management. Treatment approaches may include addressing the underlying cause, managing symptoms, and, in some cases, organ transplantation. With ongoing research and advancements in diagnostic techniques, there is a growing focus on improving outcomes for individuals affected by Cardiac Amyloidosis.